Lundbeck
HLUN-B.CO
#2621
Rank
$5.30 B
Marketcap
$5.56
Share price
-4.27%
Change (1 day)
15.10%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Market capitalization of Lundbeck (HLUN-B.CO)

Market cap: $5.30 Billion USD

As of February 2025 Lundbeck has a market cap of $5.30 Billion USD. This makes Lundbeck the world's 2621th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lundbeck from 2005 to 2025

End of year Market Cap

Year Marketcap Change
2025$5.30 B-4.73%
2024$5.57 B18.49%
2023$4.70 B30.15%
2022$3.61 B426.21%
2021$0.68 B-25.48%
2020$0.92 B-9.14%
2019$1.01 B-12.84%
2018$1.16 B-13.86%
2017$1.35 B24.56%
2016$1.08 B18.94%
2015$0.91 B72.43%
2014$0.52 B-20.71%
2013$0.66 B72.63%
2012$0.38 B-41.49%
2011$0.66 B32.88%
2010$0.49 B1.2%
2009$0.49 B-18.4%
2008$0.60 B-17.79%
2007$0.73 B-5.33%
2006$0.77 B24.95%
2005$0.61 B

End of Day market cap according to different sources

On Feb 20th, 2025 the market cap of Lundbeck was reported to be:

$5.30 Billion USD
by Yahoo Finance info icon info icon
$5.30 Billion USD
by CompaniesMarketCap info icon info icon